Print

Zalicus Inc. (ZLCS) Reports Financial Results for the Third Quarter 2012  
11/8/2012 10:04:46 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today reported financial results for the third quarter ended September 30, 2012.
//-->